Faster access to effective cancer treatments through new Cancer Drugs Fund
New arrangements for the Cancer Drugs Fund have been approved by NICE’s Board. NICE will now be able to make decisions on cancer drugs faster than ever before.
For the first time NICE will issue draft guidance on new cancer drugs or significant new licence indications before they have received marketing approval in the UK. Any drug that receives a positive draft recommendation would then be funded from the point of licence.
Read more here